People and Business News — 2/23
People News
Velocity Clinical Research has expanded its European senior executive team. Évelyne Newton joins as Vice President of Business Development, Sandra Stark as Vice President of European Operations and Maria Lehretz is the new Medical Director.
MMS Holdings announced the appointment of Chris Schoonmaker as Chief Operating Officer and Ashu Tandon as Chief Commercial Officer.
Sunitha Mathew, MS, has joined Westat's leadership team as its new Clinical Research Practice Director.
Clinical ink announced that healthcare industry veteran Jonathan Goldman MD has joined the company as Chief Executive Officer.
Business News
Vakzine Projekt Management GmbH announced the successful completion of a clinical client project with AntiBKV, an antibody targeting BK polyomavirus infection in renal transplant patients, for Memo Therapeutics AG, Switzerland.
Spaulding Clinical announced early results for a clinical trial as a part of the FDA’s proactive effort to address the opioid crisis and reduce opioid overdoses and deaths.
Verisense Health, Inc. announced the four founding members of its Board of Advisors – Dr. William Crown, Paul Hartung, Dr. Ronald C. Kessler, and Josh Tolkoff.
Medidata announced it was positioned as a Leader in the IDC MarketScape “Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment (doc #US48061722).”
OCT Clinical announced they have successfully completed the enrollment of 3,000 patients in a COVID-19 vaccine study.
Recognition
Almac Group has won six CDMO Leadership Awards for 2023: Excellence in Capabilities (Small Pharma), Compatibility (Overall and Small Pharma), Expertise (Overall and Small Pharma), Quality (Overall and Small Pharma), Reliability (Overall and Small Pharma), and Service (Small Pharma).
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
